WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Down – Should You Sell?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) gapped down before the market opened on Wednesday . The stock had previously closed at $19.7136, but opened at $18.56. WuXi AppTec shares last traded at $18.56, with a volume of 407 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research upgraded WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

WuXi AppTec Trading Down 5.9%

The firm’s fifty day moving average is $17.06 and its 200 day moving average is $15.46.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings results on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.